Search Results for: Tilray

Tilray Launches New High-CBD Cannabis Oil

Tilray_2100

CANADA:  Tilray, a leader in medical cannabis cultivation, distribution, and research, has launched its newest product, Tilray 2:100, a high-CBD cannabis oil. Designed for patients with significant unmet medical need, Tilray 2:100 contains the highest concentration of cannabis-extracted CBD in a medical cannabis product available through Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). Read the full article…

Tilray Shares Preliminary Data From The Largest National Longitudinal Medical Cannabis Patient Study in Canada

Study finds significant reduction in opioid use and improvements in quality of life within first 6 months.

CANADA: Tilray Canada Ltd., a medical cannabis leader committed to advancing scientific knowledge of cannabinoids, shared preliminary data today from the Tilray Observational Patient Study (TOPS), a Tilray-sponsored survey of medical cannabis patients using Tilray products currently underway at 18 different medical clinics in five provinces in Canada. As Canada’s largest national medical cannabis longitudinal study, Read the full article…

Tilray Launches High Park Company to Produce And Distribute Adult-Use Cannabis In Canada

High Park Farms in Enniskillen, Ontario

CANADA: In anticipation of the historic legalization of adult-use cannabis in Canada,  Tilray has announced the creation of wholly-owned subsidiary High Park Company to produce and distribute a broad-based portfolio of cannabis brands and products. As a part of this announcement, the company announced it will be making an investment of up to $10 million in a new facility located in Read the full article…

Tilray Signs Letter Of Intent With Pharmasave

Tilray® Signs Letter of Intent with Pharmasave

CANADA:  Tilray Canada announced that it has entered into a Letter of Intent (LOI) to become a preferred medical cannabis supplier to Pharmasave, the premier independent pharmacy banner in Canada. Subject to changes to Canadian regulations that would allow such distribution, Tilray will supply and distribute Good Manufacturing Practices (GMP) certified Tilray-branded medical cannabis products through Pharmasave pharmacists. Read the full article…

Tilray Forms Strategic Alliance With Leading Pharmaceutical Company In Canada

Agreement represents major milestone recognizing medical cannabis as a conventional medicine for patients in need

CANADA: Tilray, a federally licensed producer of medical cannabis, announced today that it has signed a binding letter of intent (LOI) to be the exclusive collaborator of a major pharmaceutical company to accelerate innovation and increase availability of high quality medical cannabis products. Through this LOI and the anticipated definitive agreements, Tilray is allied with Sandoz Read the full article…

Tilray Exports Medical Cannabis To South Africa

Tilray goes to South Africa

First-ever export of plant-derived cannabinoid product to the continent of Africa CANADA: Tilray, a global pioneer in cannabis cultivation, processing and distribution, today announced that it has successfully exported medical cannabis products to South Africa for nationwide distribution to qualified patients through pharmacies. Tilray’s product is the first cannabinoid-based product derived from the cannabis plant that has Read the full article…

Tilray Signs LOI with Société des Alcools du Québec (SAQ) To Supply Province With Cannabis

Tilray Canada inks deal with SAQ

CANADA: Tilray, a global pioneer in cannabis cultivation, processing and distribution, has signed a Letter of Intent (LOI) with Société des alcools du Québec (SAQ) to supply the province of Quebec with high-quality cannabis products in anticipation of adult-use legalization later this year. “This LOI is another major milestone for us as we aim to build Read the full article…

Tilray Announces Completion Of Series A Funding Round Led by Global Institutional Investors

Tilray closes Series A Round

C$60 million Series A financing will enable Tilray to increase production capacity and expand distribution in North America and Europe CANADA:  Tilray has announced the completion of its Series A funding round totaling C$60 million. The round was comprised of a group of leading global institutional investors. According to a company press release, Tilray will use Read the full article…

Tilray Exports Medical Cannabis Genetics To The European Union

Europe is going green

PORTUGAL: Tilray, a GMP-certified global leader in medical cannabis research and production, today announced that the company has successfully exported live medical cannabis genetics from its flagship British Columbia, Canada facility to its European Union Campus in Cantanhede, Portugal. The announcement is the first time a company has legally exported live cannabis genetics from North America Read the full article…

Tilray Exports Medical Cannabis Products To New Zealand or Nationwide Distribution

Products currently available in New Zealand include precisely formulated medical cannabis oils containing tetrahydrocannabinol (THC) and cannabidiol (CBD).

CANADA: Tilray, a global leader in medical cannabis research and production, today announced that Tilray medical cannabis products have been successfully exported to New Zealand and are now available for distribution nationwide. The products were produced at Tilray’s federally licensed, Good Manufacturing Practice (GMP)-certified facility in Canada and can be dispensed to any patient with valid Read the full article…